NCT04756479View on ClinicalTrials.gov

Mortality Due to COVID-19 in the COVID-AGEBRU Study

CompletedOBSERVATIONAL
Enrollment

160

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Covid19Old Age; DebilityMorbidity, Multiple
Trial Locations (1)

1020

CHU Brugmann, Brussels

All Listed Sponsors
lead

Brugmann University Hospital

OTHER

NCT04756479 - Mortality Due to COVID-19 in the COVID-AGEBRU Study | Biotech Hunter | Biotech Hunter